Respiratory therapies mark the future of healthcare. The personalization of these therapies, moving away from a closed and static model, would improve the capacity of the healthcare system. These changes would result in a minimum budget saving of 30 million euros and would improve patient care, according to a report by EY.
Due to the pandemic context, added to the chronicity, smoking, and the aging of the population, it is considered an increased risk that someone receives respiratory therapy for the first time in Spain: a circumstance that generates greater economic stress for the healthcare system.
The EY report stresses the need to make clinical care more specific and proposes segmenting care, which would lead to better care for the citizen. It also addresses the current management of the so-called “non-compliant patient”. In this regard, it is claimed that, with more personalized treatment, patient loyalty would increase as they would feel better cared for.
Read more on the subject and find the most important financial news in the world with the Born2Invest mobile app.
According to the consultant’s report, the annual evolution of patients is currently between 8% and 12% on average, but financing does not follow the same line
The resulting savings would de-stress healthcare services due to fewer visits and hospitalizations. EY also proposes to increase the financial resources allocated to respiratory therapies, which would guarantee the quality of the service for a population increasingly exposed to these treatments.
According to the consulting firm’s report, the current annual increase in the number of patients requiring respiratory therapy is, on average, between 8% and 12%. Funding does not follow the same line. In this section, the increase contemplated in budgets and tenders, since it is a public-private partnership, is only 3%. This percentage is equivalent to providing care for only 30% of new patients.
The autonomous communities apply different healthcare policies, a fact which puts the equity of citizens at risk
The management of public competencies is an added problem. In Spain, the autonomous communities apply different health policies with respect to these therapies, and the equity of citizens in accessing treatments with the same quality standards is put at risk.
The transition proposed by EY, evolving towards the personalization of respiratory therapies, would put Spain in the same context as other countries in the region. In these cases, the patient assumes the responsibility of deciding which service proposal is best suited to his or her situation.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [1xBet Affiliate Program]
Wanna discover one weird sports betting niche with plenty of low-hanging fruit just waiting for you to exploit? Then read...
Which Are the Most Important Fintech News from February 2024
Monite secured $6 million in a top-up financing round, bringing its total seed-stage funding to $16 million. The funds will...
Spanish Pharma Listed Companies Reduce Their Profits by 37% in 2023
Of the Spanish pharma listed companies, PharmaMar has suffered the most significant drop in profits due to generic drug competition...
How Much Does Europe Invest in Sustainability
Europe is moving rapidly towards a renewal of the regulatory framework for sustainability , with the obligation for almost 50,000...
The German Medical Cannabis Market Could Be Worth Three Billion
Currently, the German medical cannabis market serves a relatively small part of the population, with approximately 28,000 patients, or less...
Biotech2 weeks ago
Haier Receives Authorization from the Cnmc to Buy 20% of Shanghai Raas from Grifols
Impact Investing4 days ago
Guarantee Fund in Italy Brings Maximum Business Coverage to 5 Million
Biotech1 week ago
Gotham Insists on Projecting Its Doubts on Grifols
Crypto2 days ago
Bitcoin, Soon an ATH of 70,000: Investors also FOMO These 5 Cryptos